Q1 26 EPS
$0.97
Q1 26 Revenue
$5.32B
BEAT +2.08%
Est. $5.22B
Did CL Beat Earnings? Q1 2026 Results
Colgate-Palmolive delivered a broad-based beat in Q1 2026, extending its EPS consensus beat streak to four consecutive quarters as the consumer products giant posted adjusted earnings of $0.97 per share, ahead of the $0.94 consensus by 2.70%, while r… Read more Colgate-Palmolive delivered a broad-based beat in Q1 2026, extending its EPS consensus beat streak to four consecutive quarters as the consumer products giant posted adjusted earnings of $0.97 per share, ahead of the $0.94 consensus by 2.70%, while revenue climbed 8.4% year over year to $5.32 billion, topping estimates by 2.08%. The headline growth was powered by a combination of organic sales expansion and a meaningful foreign exchange tailwind, with international divisions leading the charge; Latin America stood out with 14.8% net sales growth, while North America remained a soft spot, posting a 1.8% net sales decline on volume weakness. Restructuring charges tied to the company's expanded Strategic Growth and Productivity Program weighed on GAAP results, pushing diluted GAAP EPS down 6% to $0.80, even as the underlying business demonstrated resilience. Looking ahead, management maintained its full-year net sales growth guidance of 2% to 6% but revised gross margin expectations downward on both a GAAP and adjusted basis, citing the evolving tariff environment as a key headwind for the remainder of 2026.
Key Takeaways
- • Organic sales growth of 2.9% driven by balance of volume and pricing growth
- • Foreign exchange provided a 5.1% tailwind to total company net sales
- • Latin America strongest division with 5.4% organic sales growth and 9.5% FX benefit
- • Asia Pacific delivered strongest organic sales growth at 5.6%
- • Advertising spending increased to $734 million from $668 million year over year
- • Emerging markets organic sales grew 6.2% with 3.5% volume growth
- • Gross profit margin increased sequentially versus Q4 2025
CL Forward Guidance & Outlook
For full year 2026, based on current spot rates and including the estimated impact of tariffs announced and finalized as of April 29, 2026: Net sales expected to be up 2% to 6%, including a low-single-digit positive impact from foreign exchange. Organic sales growth expected to be 1% to 4%, including impact from the exit from the private label pet food business. On a GAAP basis, gross profit margin is now expected to be down (versus up previously); advertising expected to be up on both a dollar basis and as a percentage of net sales; double-digit EPS growth expected. On a Base Business (non-GAAP) basis, gross profit margin is now expected to be down (versus up previously); advertising expected to be up; low to mid-single-digit EPS growth expected.
CL YoY Financials
Q1 2026 vs Q1 2025, source: SEC Filings
CL Revenue by Segment
With YoY comparisons, source: SEC Filings
CL Revenue by Geography
With YoY comparisons, source: SEC Filings
“We delivered a strong start to 2026, with broad-based top and bottom-line growth. Net sales and organic sales grew in every category and in four of five divisions with a nice balance of volume and pricing growth. Gross profit margin increased sequentially versus fourth quarter 2025 and operating profit, net income, earnings per share and free cash flow all increased year over year along with an increase in advertising spending.”
— Noel Wallace, Q1 2026 Earnings Press Release
CL Earnings Trends
CL vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
CL EPS Trend
Earnings per share: estimate vs actual
CL Revenue Trend
Quarterly revenue: estimate vs actual
CL Quarterly Results
5 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q1 26 | — | $0.97 | — | $5.32B | +2.08% |
| Q4 25 BEAT FY | $0.91 | $0.95 | +4.40% | $5.23B | +2.04% |
| FY Full Year | $3.65 | $3.69 | +1.00% | $20.38B | +0.52% |
| Q3 25 BEAT | $0.89 | $0.91 | +2.36% | $5.13B | +0.04% |
| Q2 25 BEAT | $0.89 | $0.92 | +2.80% | $5.11B | +1.55% |
| Q1 25 BEAT | $0.86 | $0.91 | +6.11% | $4.91B | +0.98% |